Sign In
Buy MDRX
$4.75
+0.250 (+5.56%)
At Close: Jun 03, 2026
HealthEquity (HQY) Q4 Earnings Lag Estimates, Margins Down
01:34pm, Thursday, 24'th Mar 2022 Zacks Investment Research
HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.
EDOC: Healthcare Technology Needs Time To Reach Its Potential
04:44am, Thursday, 24'th Mar 2022
EDOC: Healthcare Technology Needs Time To Reach Its Potential
Reasons to Add Allscripts (MDRX) Stock to Your Portfolio
04:51pm, Monday, 21'st Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.
Catalent's (CTLT) New Project Completion Expands Global Footprint
04:47pm, Monday, 21'st Mar 2022 Zacks Investment Research
Catalent's (CTLT) latest facility transformation is likely to significantly enhance the global Biologics business.
Reasons to Add Allscripts (MDRX) Stock to Your Portfolio
02:18pm, Monday, 21'st Mar 2022
Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.
Where Allscripts Healthcare Stands With Analysts
04:03pm, Friday, 18'th Mar 2022 Benzinga
Allscripts Healthcare (NASDAQ:MDRX) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
1
0
0
Masimo's (MASI) New Product Expansion to Boost Patient Outcome
02:00pm, Friday, 18'th Mar 2022 Zacks Investment Research
Masimo's (MASI) latest feature additions to its telehealth for Patient SafetyNet are likely to significantly improve patient outcomes.
Medtronic (MDT) Boosts Surgical Robotics Wing With New Deal
01:40pm, Friday, 18'th Mar 2022 Zacks Investment Research
According to Medtronic (MDT), Touch Surgery Enterprise is the first AI-powered platform of its kind for the operating room (OR). It is compatible with Medtronic's Hugo robotic-assisted surgery (RAS) s
Surging Earnings Estimates Signal Upside for AllScripts (MDRX) Stock
04:20pm, Thursday, 17'th Mar 2022 Zacks Investment Research
AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio
02:30pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.
Surging Earnings Estimates Signal Upside for AllScripts (MDRX) Stock
01:32pm, Thursday, 17'th Mar 2022
AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why You Should Retain Baxter (BAX) Stock For Now
03:39pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio.
Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now
04:55pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
PerkinElmer's (PKI) Latest Launch to Boost Food Analysis Suite
04:31pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
PerkinElmer's (PKI) latest launch is likely to simplify the process of critical food analyses.
McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?
03:26pm, Monday, 14'th Mar 2022 Zacks Investment Research
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
